文献速递妇科产科

卵巢成人型颗粒细胞瘤的子宫内膜病理与手术范围:与分期和生存的关联

Endometrial pathology and surgical extent in ovarian adult granulosa cell tumor: associations with stage and survival.
PubMed 文献 · Am J Obstet Gynecol · 2026-02-16

该回顾性队列纳入丹麦2007–2021年252例及荷兰2000–2021年195例组织学确诊的卵巢成人型颗粒细胞瘤患者,评估合并子宫内膜异常对手术范围和总生存的影响,以及手术范围与复发的关联。结果显示异常子宫出血、子宫内膜增生和子宫内膜癌与较低FIGO分期相关,完整分期手术未改善无进展生存。

要点

  • 异常子宫出血、子宫内膜增生和子宫内膜癌与较低FIGO分期相关,提示有助于早期发现肿瘤。
  • 子宫内膜癌未影响总生存(HR=0.8,95%CI:0.21–3.16)。
  • 完整分期手术与保守手术的无进展生存无差异(HR=1.37,95%CI:0.65–2.88)。

核心结论

  • 异常子宫出血、子宫内膜增生和子宫内膜癌与较低的FIGO分期相关,提示这些因素促进成人型颗粒细胞瘤的早期发现,且未对总生存造成不利影响。
  • 完整手术分期与成人型颗粒细胞瘤患者无进展生存改善无关。
  • 较高的FIGO分期(IC期或更高)与IA和IB期相比复发率增加。

研究设计与样本

  • 回顾性队列研究,纳入丹麦2007年1月至2021年12月组织学确诊的卵巢成人型颗粒细胞瘤患者252例。
  • 合并分析纳入荷兰成人型颗粒细胞瘤队列2000年1月至2021年12月患者195例,合计n=447。
  • 丹麦队列中位随访7.2年,荷兰队列中位随访3.2年,复发率分别为18%和42%。
  • 手术分为完整分期(含子宫切除、双侧输卵管卵巢切除、大网膜和腹膜活检及腹腔冲洗)与临床分期的较小范围手术。

主要发现

  • 丹麦队列中,异常子宫出血与接受较小范围手术相关(OR=0.35,95%CI:0.18–0.66),子宫内膜增生亦与较小范围手术相关(OR=0.39,95%CI:0.19–0.76)。
  • 异常子宫出血(OR=0.32,95%CI:0.15–0.64)、子宫内膜增生(OR=0.28,95%CI:0.12–0.6)和子宫内膜癌(OR=0.16,95%CI:0.01–0.94)分别与较低的FIGO分期相关。
  • 丹麦队列中子宫内膜癌未影响总生存(HR=0.8,95%CI:0.21–3.16)。
  • 完整分期与保守治疗的无进展生存无差异(HR=1.37,95%CI:0.65–2.88)。
  • FIGO IC期(HR=9.4,95%CI:4.0–22.29)和II–III期(HR=8.4,95%CI:2.9–24.17)较IA或IB期复发率更高。

关键数值与推荐

  • 丹麦与荷兰合并队列分析结果与丹麦队列观察到的估计值一致。

临床怎么用

  • 合并子宫内膜异常(异常子宫出血、增生或癌)的成人型颗粒细胞瘤患者分期往往较低,可考虑对这类表现保持警惕以促进早期诊断。
  • 完整分期手术未显示无进展生存获益,手术范围决策可结合临床分期与患者情况个体化考虑。
  • FIGO IC期及以上患者复发风险明显升高,需加强随访监测。

局限性

  • 回顾性队列设计,存在选择偏倚和信息偏倚可能。
  • 丹麦与荷兰队列随访时间不同(7.2年与3.2年),复发率差异较大(18%与42%)。
  • 原文未报告多因素校正模型的具体调整变量。

以上解读依据论文摘要(全文未开放获取或许可不允许翻译转载)。

原文

BACKGROUND: Adult granulosa cell tumor is a rare ovarian cancer with less aggressive behavior than epithelial ovarian cancer. However, recurrence occurs in up to 30% of patients and is challenging to manage, as treatment options are limited. Additionally, adult granulosa cell tumor has been linked to synchronous endometrial pathology, including endometrial hyperplasia and cancer, but the impact of these abnormalities on surgical decision-making and survival outcomes remains unclear. OBJECTIVE: To evaluate how coexisting endometrial abnormalities influence surgical management and overall survival, and to examine the association between surgical extent (conservative vs complete staging) and recurrence in patients with adult granulosa cell tumor. STUDY DESIGN: This retrospective cohort study included all patients diagnosed with histologically confirmed ovarian adult granulosa cell tumor in Denmark between January 2007 and December 2021. Analyses were first conducted in the comprehensive nationwide Danish cohort, and results were subsequently compared in a combined analysis including data from a Dutch adult granulosa cell tumor cohort (January 2000-December 2021). Surgical procedures were categorized as complete staging (including hysterectomy, bilateral salpingo-oophorectomy, omental and peritoneal biopsies, and peritoneal washings) or less extensive surgery with clinical staging. Abnormal uterine bleeding and endometrial pathology were identified, and their associations with surgical extent and International Federation of Gynecology and Obstetrics stage were assessed. Progression-free survival was compared with surgical extent and International Federation of Gynecology and Obstetrics stage. RESULTS: A total of 252 Danish and 195 Dutch patients (n=447) were included, with median follow-up times of 7.2 and 3.2 years, and recurrence rates of 18% and 42%, respectively. In the Danish cohort, abnormal uterine bleeding and endometrial hyperplasia were associated with receiving less extensive surgery (odds ratio=0.35, 95% confidence interval: 0.18-0.66 and odds ratio=0.39, 95% confidence interval: 0.19-0.76). Furthermore, abnormal uterine bleeding, endometrial hyperplasia, and endometrial cancer were each associated with lower International Federation of Gynecology and Obstetrics stage at diagnosis of adult granulosa cell tumor (odds ratio=0.32, 95% confidence interval: 0.15-0.64; odds ratio=0.28, 95% confidence interval: 0.12-0.6; and odds ratio=0.16, 95% confidence interval: 0.01-0.94, respectively). In the Danish cohort, overall survival was not affected by endometrial cancer (hazard ratio=0.8, 95% confidence interval: 0.21-3.16). No difference in progression-free survival was observed between patients undergoing complete staging and those managed conservatively (hazard ratio=1.37, 95% confidence interval: 0.65-2.88). International Federation of Gynecology and Obstetrics stage IC (hazard ratio=9.4, 95% confidence interval: 4.0-22.29) and stage II-III (hazard ratio=8.4, 95% confidence interval: 2.9-24.17) had higher rates of recurrences compared with those with International Federation of Gynecology and Obstetrics stage IA or IB. Analyses of the combined Danish and Dutch cohorts demonstrated estimates consistent with those observed in the Danish cohort. CONCLUSION: The presence of abnormal uterine bleeding, endometrial hyperplasia, and endometrial cancer was associated lower International Federation of Gynecology and Obstetrics stage, suggesting that these factors facilitate earlier detection of adult granulosa cell tumor without adversely affecting overall survival. Complete surgical staging is not associated with improved progression-free survival in patients with adult granulosa cell tumor. Higher International Federation of Gynecology and Obstetrics stage (IC or higher) was, as expected, associated with an increased rate of recurrence compared to stage IA and IB.

来源:Am J Obstet Gynecol,查看原文。版权归原作者所有。

引用

  1. Karstensen S, Brink GJ, Jochumsen K, et al. Endometrial pathology and surgical extent in ovarian adult granulosa cell tumor: associations with stage and survival. Am J Obstet Gynecol. 2026. PMID: 41707897. doi:10.1016/j.ajog.2026.02.019

供执业医师工作参考,不替代临床判断;数值与分级以指南原文为准。